Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccines: a review.

P J Lewis1, L A Babiuk

  • 1Veterinary Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.

Advances in Virus Research
|November 5, 1999
PubMed
Summary

DNA vaccines show promise for various diseases, including HIV, but are not a universal solution. Further research into their basic science and applications is crucial for their success in the immunological arsenal.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural and inducible regulatory B cells are widely distributed in ovine lymphoid tissues.

Veterinary immunology and immunopathology·2019
Same author

Evidence for the existence of regulatory and effector B cell populations in Peyer's patches of sheep.

Veterinary immunology and immunopathology·2016
Same author

Review: Capripoxvirus Diseases: Current Status and Opportunities for Control.

Transboundary and emerging diseases·2015
Same author

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.

Vaccine·2012
Same author

Veterinary DNA vaccines.

Methods in molecular medicine·2011
Same author

Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.

Journal of viral hepatitis·2010

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Clinical trials for DNA vaccines against pathogens and cancers are rapidly progressing.
  • The development of DNA vaccine technology, including human immunodeficiency virus (HIV) gp160 DNA-based vaccines, has been remarkably swift.
  • Despite rapid advancement, DNA vaccines are not considered an immunological 'silver bullet'.

Purpose of the Study:

  • To evaluate the current status and future potential of DNA vaccine technology.
  • To explore the basic science, mechanisms, and applications of DNA vaccines in target species.
  • To discuss the role of DNA vaccines as a novel option for diseases unresponsive to conventional vaccines.

Main Methods:

  • Review of ongoing clinical trials and published research on DNA vaccines.
  • Analysis of DNA vaccine-mediated protection against heterologous challenge with HIV-1 in chimpanzees.
  • Discussion of spinoff research, including immunomodulatory DNA sequences and rapid assessment methodologies.

Main Results:

  • DNA vaccine trials have progressed rapidly, demonstrating potential in various applications.
  • Studies in chimpanzees showed transient viraemia and seronegativity for one year after challenge with HIV-1.
  • DNA vaccines can induce potent Th1-type immune responses, potentially beneficial for allergic and autoimmune disorders.

Conclusions:

  • DNA vaccine technology is a powerful and novel tool in disease control, moving beyond initial phenomenological studies.
  • Further research is essential to define the basic science, understand mechanisms, and optimize applications for target species.
  • Continued investigation, free from impatience and with adequate funding, is vital to realize the full potential of DNA vaccines.

Related Experiment Videos